Stocksigma LogoStocksigma Logo

AstraZeneca Pharma India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

■ Revenue: 7,291 (+30.4% YoY | +6.8% QoQ) ■ EBITDA: 956 (+27.1% YoY | +95.3% QoQ) ■ EBITDA Margin (%): 13.1 (-34 bps YoY | +594 bps QoQ) ■ PAT: 623 (+15.0%

AstraZeneca Pharma India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

AstraZeneca Pharma India Ltd · Outcome · 05 Nov 2026, 11:07 pm

AstraZeneca Pharma India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 7,291 (+30.4% YoY | +6.8% QoQ) ■ EBITDA: 956 (+27.1% YoY | +95.3% QoQ) ■ EBITDA Margin (%): 13.1 (-34 bps YoY | +594 bps QoQ) ■ PAT: 623 (+15.0% YoY | +64.3% QoQ) ■ EPS (INR): 24.9 (+14.9% YoY | +64.3% QoQ)

Original exchange filing (PDF)

More announcements from AstraZeneca Pharma India Ltd

All AstraZeneca Pharma India Ltd announcements